Board of Directors
Anti-influenza Drug And Anti-Gram Negative Bacteria Drug
Corporate brief introduction
Institutional investors conference on Jul. 06, 2016
CLSA China Healthcare-Drug Innovation Forum on Jan. 20-21,2016
Morgan Stanley Fourteenth Annual Asia Pacific Summit on Nov. 17-18,2015
CIMB Pan-Asia Healthcare Conference on Oct. 8-9, 2015
- TaiGen Biotechnology Receives Market Approval from the China Food and ...
- TaiGen Presented Clinical Data of Furaprevir (TG-2349) at the Internat...
- TaiGen Biotechnology Signed Memorandum of Understanding for Novel Chro...
- TaiGen Biotechnology Presented Phase 2 Data for Burixafor at the 2015 ...
- TaiGen Biotechnology Launches Taigexyn in Taiwan
Novel Stem Cell Mobilizer
Hepatitis C Virus Protease Inhibitor
Copyright © 2014 TaiGen Biotechnology Co., Ltd.